531 related articles for article (PubMed ID: 33019919)
1. Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade.
Sohail M; Guo W; Li Z; Xu H; Zhao F; Chen D; Fu F
Curr Med Chem; 2021; 28(19):3753-3772. PubMed ID: 33019919
[TBL] [Abstract][Full Text] [Related]
2. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
5. Nanocarriers for Anticancer Drug Targeting: Recent Trends and Challenges.
Dahiya S; Dahiya R; Hernández E
Crit Rev Ther Drug Carrier Syst; 2021; 38(6):49-103. PubMed ID: 34587429
[TBL] [Abstract][Full Text] [Related]
6. Cancer chemotherapy with lipid-based nanocarriers.
Liu D; Zhang N
Crit Rev Ther Drug Carrier Syst; 2010; 27(5):371-417. PubMed ID: 21083528
[TBL] [Abstract][Full Text] [Related]
7. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
9. Updates on the use of liposomes for active tumor targeting in cancer therapy.
Yan W; Leung SS; To KK
Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
[TBL] [Abstract][Full Text] [Related]
10. Micelles as potential drug delivery systems for colorectal cancer treatment.
Fatfat Z; Fatfat M; Gali-Muhtasib H
World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
[TBL] [Abstract][Full Text] [Related]
11. Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy.
Bhatia R; Sharma A; Narang RK; Rawal RK
Curr Mol Pharmacol; 2021; 14(3):350-366. PubMed ID: 32744982
[TBL] [Abstract][Full Text] [Related]
12. Colloidal Nanocarriers as Versatile Targeted Delivery Systems for Cervical Cancer.
Sugumaran A; Mathialagan V
Curr Pharm Des; 2020; 26(40):5174-5187. PubMed ID: 32586249
[TBL] [Abstract][Full Text] [Related]
13. Combinations of chemo-, immuno-, and gene therapies using nanocarriers as a multifunctional drug platform.
Hopkins C; Javius-Jones K; Wang Y; Hong H; Hu Q; Hong S
Expert Opin Drug Deliv; 2022 Oct; 19(10):1337-1349. PubMed ID: 35949105
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
[TBL] [Abstract][Full Text] [Related]
15. Passive and active tumour targeting with nanocarriers.
Hirsjärvi S; Passirani C; Benoit JP
Curr Drug Discov Technol; 2011 Sep; 8(3):188-96. PubMed ID: 21513482
[TBL] [Abstract][Full Text] [Related]
16. Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms.
Kaushik N; Borkar SB; Nandanwar SK; Panda PK; Choi EH; Kaushik NK
J Nanobiotechnology; 2022 Mar; 20(1):152. PubMed ID: 35331246
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
[TBL] [Abstract][Full Text] [Related]
18. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
Tanbour R; Martins AM; Pitt WG; Husseini GA
Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
[TBL] [Abstract][Full Text] [Related]
19. Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer management.
Phillips MC; Mousa SA
Nanomedicine (Lond); 2022 Mar; 17(6):405-421. PubMed ID: 35118878
[TBL] [Abstract][Full Text] [Related]
20. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review.
Hossen S; Hossain MK; Basher MK; Mia MNH; Rahman MT; Uddin MJ
J Adv Res; 2019 Jan; 15():1-18. PubMed ID: 30581608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
